Best Stocks to Invest in 2025: Expert Picks and Essential Tips

HMA Agro Industries Limited, a prominent FMCG player in the food trade sector specializing in processed food and agro products, including frozen buffalo meat, fruits, vegetables, and cereals, has surged to the 10% upper circuit limit after impressive quarterly results. The company reported a 105.7% increase in revenue QoQ, reaching ₹1,465.86 crore, and an astonishing 7,219.18% rise in net profit, amounting to ₹53.43 crore.

Stock Movement

The share price of HMA Agro Industries hit the upper circuit at ₹45.3 per share on Tuesday, marking a substantial increase from its prior close of ₹41.15. The stock’s market capitalization now stands at ₹2,266.48 crore as of November 12, 2024.

Q2 FY25 Results Highlights

HMA Agro Industries’ quarterly results reveal a strong performance:

• Revenue Growth: The company's revenue increased by 22.14% YoY, reaching ₹1,465.86 crore in Q2 FY25, and grew by 105.7% from ₹712.61 crore in Q1 FY25.
• EBITDA Margin: Improved by 246 basis points YoY, now at 2.32%.
• Net Profit: Consolidated net profit grew to ₹53.43 crore, reflecting an 847.34% increase YoY and a staggering 7,219.18% rise QoQ.
• EPS: Basic earnings per share rose by 3,366.67%, reaching ₹1.04.
• Return Ratios: ROE and ROCE are now 16.2% and 14%, respectively, with a debt-to-equity ratio of 0.72x.

Shareholding Pattern

As of September 2024, HMA Agro Industries’ shareholding pattern shows a 63.42% stake held by promoters, 1.01% by foreign institutional investors, 3.12% by domestic institutional investors, 10% by the government of India, and 2.92% by the public.

Disclaimer: We are not SEBI-registered analysts. This content is for informational purposes only and should not be considered investment advice. Always conduct your own research or consult a qualified financial advisor before making any investment decisions.

As of November 8, 2024, Indian Renewable Energy Development Agency (IREDA) shares declined by 2.55%, closing at ₹200.8, down from the previous closing price. Despite an opening at ₹206, IREDA experienced a high of ₹206 and a low of ₹200 during the trading session. Similarly, benchmark indices Sensex and Nifty are also trading lower, with Sensex down 0.07% at ₹79,486.32 and Nifty down 0.21%.

Technical Analysis of IREDA Stock

On the technical front, IREDA’s stock remains above its 300-day Simple Moving Average (SMA) of ₹196.37 but is below its 5, 10, 20, 50, and 100-day SMAs. The specific SMA values for different timeframes are as follows:

• 5-day SMA: ₹208.40
• 10-day SMA: ₹203.81
• 20-day SMA: ₹212.03
• 50-day SMA: ₹224.90
• 100-day SMA: ₹228.88
• 300-day SMA: ₹196.37

Given this pattern, the 300-day SMA offers support, while shorter-term SMAs indicate potential resistance.

Using pivot level analysis, the stock faces resistance at ₹204.35, ₹207.62, and ₹209.3. Key support levels are identified at ₹199.4, ₹197.72, and ₹194.45.

Trading Volume

Trading volume for IREDA on both NSE and BSE is 64.35% lower than the previous session, indicating low trading activity. Volume analysis is critical alongside price movements, as positive price action with high volume signals a sustainable uptrend, whereas a price drop with high volume might suggest further downside.

Fundamentals at a Glance

From a fundamental perspective, IREDA has a Return on Equity (ROE) of 17.28% and a Return on Assets (ROA) of 2.22%. The stock’s current P/E ratio is 37.42 with a P/B ratio of 5.93. The stock's 1-year median target price is ₹195.00, which represents an upside potential of 2.89%.

Institutional Holdings

In the September quarter, IREDA's mutual fund (MF) holdings decreased to 0.16% from 0.18% in June. Foreign Institutional Investors (FII) holdings also dropped from 2.70% in June to 2.02% in September. Notably, IREDA’s promoter holding stands at 0.00%, which is uncommon among its peers.

Peer Performance

On a mixed trading day, IREDA’s peers in the infrastructure and pharma sectors displayed varying performance. While some companies like JSW Infrastructure, Tata Technologies, and Piramal Pharma faced declines, certain others managed to rise. Overall, market indices Nifty and Sensex remain slightly negative, impacting IREDA and its sector.

Disclaimer: This article is for informational purposes only and is not financial advice. We are not SEBI-registered analysts. Investors should conduct their own research or consult a financial advisor before making any investment decisions.

Bharat Electronics Limited (BEL), a leader in defence equipment manufacturing, recently secured a substantial order worth ₹500 crore, marking another step in its steady growth trajectory. Following this announcement, BEL shares rose up to 2% before settling at ₹298.50, a slight dip of 0.57% compared to the previous closing at ₹300.20. With a market capitalization of approximately ₹2.18 lakh crore, BEL remains a significant player in India's defence sector.

Why the Surge in Orders?

BEL's recent ₹500 crore order encompasses an array of essential defence equipment, including laser range finders, communication systems, test equipment for weaponry, and support services. This order brings BEL’s total secured orders for the fiscal year to ₹8,194 crore. Such contracts reflect the company's solid standing in the defence sector and its ability to meet the sophisticated needs of India's defence apparatus.

Financial Performance

BEL’s financial results showcase impressive growth, with Q2 FY25 revenue rising by 15% to ₹4,605 crore from ₹4,009 crore in Q2 FY24. Meanwhile, net profit saw an even more substantial increase, surging by 38% YoY to ₹1,093 crore. This consistent growth demonstrates BEL’s ability to drive revenue while maintaining profitability.

Order Book and Growth Outlook

The company's order book stands at approximately ₹76,705 crore, with significant contracts like the ₹695 crore order announced in August 2024. BEL projects an order inflow of ₹25,000 crore this fiscal year, with a target of ₹50,000 crore over the current and following year. Notable upcoming programs include the BMP-2 Upgrade, TR Modules for Thales, and the MPR Radar for ITR Chandipur, reflecting BEL’s strong pipeline.

Margin and Profitability Goals

BEL has set ambitious targets for profitability, maintaining a gross margin range of 40% to 42% and an EBITDA margin of 23% to 25%. With a focus on indigenization, the company is working to reach 80% to 90% domestic sourcing over the next few years, further boosting its operational efficiency and cost management.

Capital Investment and Expansion

To support its growth, BEL has earmarked a capex of ₹800 crore for the current year. This investment will fund new production facilities in Palasamudram, Nimmakuru, Hyderabad, and Ibrahimpatnam, enhancing its manufacturing capacity and addressing future demand in key regions.

Strategic Collaborations and Partnerships

BEL is strengthening its global footprint through a Memorandum of Understanding with Rosoboronexport, aimed at exporting ammunition to Russia. This partnership could potentially yield ₹20,000 to ₹30,000 crore over the next five to six years. Additionally, BEL is advancing the Kavach system, with projected annual business potential of ₹4,000 to ₹5,000 crore.

Stock Performance

BEL has delivered impressive returns for shareholders, achieving a 21.16% return over the past six months and doubling investors’ returns by 100% in the past year. A ₹1 lakh investment in BEL a year ago would now be worth approximately ₹2 lakh.

Disclaimer: We are not SEBI-registered analysts. This article is for informational purposes only and should not be considered financial advice. Investors are encouraged to conduct their own research or consult a certified financial advisor before making investment decisions.